QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)

Phreesia (PHR) Stock Forecast, Price & News

$18.63
+0.78 (+4.37%)
(As of 09/28/2023 ET)
Compare
Today's Range
$17.57
$18.63
50-Day Range
$17.62
$31.91
52-Week Range
$17.44
$40.00
Volume
607,645 shs
Average Volume
423,188 shs
Market Capitalization
$1.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.15

Phreesia MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.85 Rating Score
Upside/​Downside
99.4% Upside
$37.15 Price Target
Short Interest
Healthy
3.13% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.60
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$454,810 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.64) to ($2.00) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.78 out of 5 stars

Medical Sector

71st out of 969 stocks

Health Information Services Industry

1st out of 2 stocks


PHR stock logo

About Phreesia (NYSE:PHR) Stock

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.

PHR Price History

PHR Stock News Headlines

Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Expert Ratings for Phreesia
These Analysts Slash Their Forecasts On Phreesia Following Q2 Results
Q2 2024 Phreesia Inc Earnings Call
Phreesia, Inc. (NYSE:PHR) Q2 2024 Earnings Call Transcript
Phreesia Announces Second Quarter Fiscal 2024 Results
Phreesia Q2 2024 Earnings Preview
What Wall Street expects from Phreesia's earnings
Phreesia's Earnings: A Preview
Should You Buy and Phreesia (PHR) Ahead of Earnings?
Phreesia (NYSE: PHR)
See More Headlines
Receive PHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter.

PHR Company Calendar

Last Earnings
9/06/2023
Today
9/28/2023
Next Earnings (Estimated)
12/14/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
Employees
1,576
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$37.15
High Stock Price Forecast
$43.00
Low Stock Price Forecast
$29.00
Forecasted Upside/Downside
+102.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
13 Analysts

Profitability

Net Income
$-176,150,000.00
Pretax Margin
-47.44%

Debt

Sales & Book Value

Annual Sales
$280.91 million
Book Value
$4.47 per share

Miscellaneous

Free Float
52,007,000
Market Cap
$1.01 billion
Optionable
Not Optionable
Beta
0.63
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Chaim IndigMr. Chaim Indig (Age 44)
    Co-Founder, CEO & Director
    Comp: $515k
  • Mr. Evan RobertsMr. Evan Roberts (Age 44)
    Co-Founder & COO
    Comp: $400k
  • Mr. Michael J. Davidoff (Age 50)
    Sr. VP of Payer Solutions
    Comp: $350k
  • Mr. David LinetskyMr. David Linetsky (Age 43)
    Sr. VP of Life Sciences
    Comp: $551.64k
  • Mr. Balaji Gandhi (Age 49)
    Chief Financial Officer
  • Ms. Janet M. Gunzburg (Age 57)
    VP, Principal Accounting Officer & Controller
  • Mr. Daniel Nathan (Age 46)
    Chief Technology Officer
  • Ms. Allison C. HoffmanMs. Allison C. Hoffman (Age 52)
    Gen. Counsel & Sec.
  • Ms. Maureen McKinney
    VP of Corp. Communications
  • Ms. Kharen Hauck
    VP of Marketing













PHR Stock - Frequently Asked Questions

Should I buy or sell Phreesia stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PHR shares.
View PHR analyst ratings
or view top-rated stocks.

What is Phreesia's stock price forecast for 2023?

13 brokerages have issued 12 month target prices for Phreesia's shares. Their PHR share price forecasts range from $29.00 to $43.00. On average, they predict the company's share price to reach $37.15 in the next year. This suggests a possible upside of 102.6% from the stock's current price.
View analysts price targets for PHR
or view top-rated stocks among Wall Street analysts.

How have PHR shares performed in 2023?

Phreesia's stock was trading at $32.36 on January 1st, 2023. Since then, PHR stock has decreased by 43.3% and is now trading at $18.34.
View the best growth stocks for 2023 here
.

Are investors shorting Phreesia?

Phreesia saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 1,730,000 shares, a decrease of 15.2% from the August 31st total of 2,040,000 shares. Based on an average daily volume of 410,800 shares, the short-interest ratio is presently 4.2 days.
View Phreesia's Short Interest
.

When is Phreesia's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, December 14th 2023.
View our PHR earnings forecast
.

How were Phreesia's earnings last quarter?

Phreesia, Inc. (NYSE:PHR) released its quarterly earnings data on Wednesday, September, 6th. The company reported ($0.68) earnings per share for the quarter, beating the consensus estimate of ($0.71) by $0.03. The firm earned $85.80 million during the quarter, compared to the consensus estimate of $85.26 million. Phreesia had a negative trailing twelve-month return on equity of 54.52% and a negative net margin of 47.75%. The firm's quarterly revenue was up 26.4% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.89) earnings per share.

What ETFs hold Phreesia's stock?
What guidance has Phreesia issued on next quarter's earnings?

Phreesia updated its FY 2025 earnings guidance on Wednesday, September, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $500.00 million-$500.00 million, compared to the consensus revenue estimate of $453.67 million.

What is Chaim Indig's approval rating as Phreesia's CEO?

172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Phreesia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

When did Phreesia IPO?

(PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at a price of $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

What is Phreesia's stock symbol?

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Who are Phreesia's major shareholders?

Phreesia's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.25%), Brown Advisory Inc. (6.02%), Jennison Associates LLC (4.79%), Credit Suisse AG (3.50%), Rock Springs Capital Management LP (2.43%) and Franklin Resources Inc. (2.35%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, Cheryl Pegus, David Linetsky, Edward L Cahill, Edward L Cahill, Evan Roberts, Gillian Munson, Janet Gunzburg, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, Randy Rasmussen and Thomas Altier.
View institutional ownership trends
.

How do I buy shares of Phreesia?

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phreesia's stock price today?

One share of PHR stock can currently be purchased for approximately $18.34.

How much money does Phreesia make?

Phreesia (NYSE:PHR) has a market capitalization of $1.01 billion and generates $280.91 million in revenue each year. The company earns $-176,150,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis.

How many employees does Phreesia have?

The company employs 1,576 workers across the globe.

How can I contact Phreesia?

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The official website for the company is www.phreesia.com. The company can be reached via phone at (888) 654-7473, via email at investors@phreesia.com, or via fax at 646-607-1776.

This page (NYSE:PHR) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -